A detailed history of Lynx1 Capital Management LP transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Lynx1 Capital Management LP holds 17,400 shares of CNTA stock, worth $298,584. This represents 0.1% of its overall portfolio holdings.

Number of Shares
17,400
Holding current value
$298,584
% of portfolio
0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.58 - $16.99 $149,292 - $295,626
17,400 New
17,400 $278,000
Q2 2024

Aug 14, 2024

BUY
$8.04 - $11.87 $139,895 - $206,538
17,400 New
17,400 $157,000
Q1 2024

May 15, 2024

BUY
$6.73 - $12.2 $117,102 - $212,280
17,400 New
17,400 $196,000

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.62B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Lynx1 Capital Management LP Portfolio

Follow Lynx1 Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynx1 Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Lynx1 Capital Management LP with notifications on news.